companydata.dkLICA PHARMACEUTICALS ApS: Financial statements 2012
CVR: 25332520
LICA PHARMACEUTICALS ApS (CVR 25332520) has filed annual accounts for 2012. In 2012, the company reported revenue of DKK 468,291 and a net result of DKK 953,184. The profit margin was 203.5%. Equity amounted to DKK 9,258,126. The solvency ratio was 99.8%.
- Revenue
- 468,291 kr.
- Gross Profit
- 295,665 kr.
- Profit/Loss
- 953,184 kr.
- Equity
- 9,258,126 kr.
- Total Assets
- 9,275,673 kr.
How creditworthy is LICA PHARMACEUTICALS ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2012
As of September 18, 2012, JUT NR. 2180 A/S has been appointed auditor of LICA PHARMACEUTICALS ApS.
As of May 25, 2012, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of LICA PHARMACEUTICALS ApS.
About LICA PHARMACEUTICALS ApS
LICA PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2000. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named LICA PHARMACEUTICALS A/S. The management consists of Arsalan Kharazmi. The company is owned by Arsalan Kharazmi. The company has 1 employee. In 2025, the company reported a gross profit of DKK 359,449 and a net result of DKK 450,710 compared with DKK 1,406,816 the year before. Equity amounted to DKK 24,221,286.